NASDAQ · Biotechnology

TNGX (TNGX) Stock

$26.72 +0.34% NASDAQ: TNGX Healthcare

Valuation

MetricValue
Price$26.72
Market Cap$3.32B
P/E Ratio-23.71
P/B Ratio6.93
P/S Ratio42.05
EPS (TTM)$-0.87
52-Week High$34.39
52-Week Low$4.60
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-29.48%
ROA-25.56%
ROCE-32.08%
Gross Margin-180.65%
Operating Margin-179.03%
Net Margin-1.88%
Debt/Equity0.08
Current Ratio16.09

Annual Financials (USD)

Metric20212022202320242025
Revenue$37.0M$25.0M$37.0M$42.0M$62.0M
Operating Profit$-58.0M$-111.0M$-114.0M$-146.0M$-111.0M
Net Profit$-58.0M$-108.0M$-102.0M$-130.0M$-102.0M
EPS$-0.94$-1.23$-1.08$-1.19$-0.87
Op Margin-157.1%-446.8%-312.6%-346.1%-178.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$500.0M$436.0M$403.0M$316.0M$399.0M
Total Liabilities$155.0M$187.0M$149.0M$117.0M$53.0M
Cash$143.0M$60.0M$66.0M$70.0M$112.0M
Borrowings$2.0M$41.0M$39.0M$36.0M$34.0M

Latest News

How Much Upside is Left in Tango Therapeutics (TNGX)? Wall Street Analysts Think 49.48% Zacks · Jul 22, 2026 Mizuho Raises Price Target on Tango Therapeutics to $40 From $36, Keeps Outperform Rating MT Newswires · Jul 17, 2026 Tango Therapeutics (TNGX) to Benefit From Vopimetostat + KRAS Inhibitors Combined Revenues Insider Monkey · Jul 15, 2026 2 Monster Growth Stocks Analysts Think Can Reach New Highs TipRanks · Jul 9, 2026 Tango Therapeutics Rides a New Precision Oncology Trend in 2026 Zacks · Jul 2, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-60.0M$-109.0M$-118.0M$-132.0M$-139.0M
Investing Cash Flow$-185.0M$19.0M$40.0M$85.0M$-42.0M
Financing Cash Flow$-15.0M$2.0M$2.0M$6.0M$0
Net Cash Flow$114.0M$-81.0M$6.0M$2.0M$43.0M
Free Cash Flow$-61.0M$-117.0M$-120.0M$-132.0M$-140.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-5.95%
Quick Ratio27.38
Interest Coverage—
Return 1Y322.01%
Return 3Y770.06%
Return 5Y168.22%

Ownership

Insiders Held1.17%
Institutions Held114.42%
Institutions Float Held115.78%
Institutional HolderSharesReport Date
RTW Investments LP13,300,6202026-03-31
Adage Capital Partners GP L.L.C.12,809,4852026-03-31
Boxer Capital Management, LLC10,876,2192026-03-31
TCG Crossover Management, LLC10,531,0712026-03-31
FMR, LLC9,905,9192026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About TNGX

TNGX stock trades at $26.72 with a market capitalization of $3.32B. The stock is valued at a price-to-earnings (P/E) ratio of -23.71, price-to-book of 6.93, price-to-sales of 42.05. Over the past 52 weeks the stock has ranged between $4.60 and $34.39, and currently trades 22.3% below its 52-week high.

On profitability, TNGX generates a return on equity (ROE) of -29.48%, return on capital employed of -32.08%, an operating margin of -179.03%, a net profit margin of -1.88%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides